Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease-Reference-Cited by-同舟云学术

Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease

Published:2019-09-01 Issue:6 Volume:16 Page:1130-1142
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Yazdankhah Meysam¹,Shang Peng¹,Ghosh Sayan¹,Bhutto Imran A.¹,Stepicheva Nadezda¹,Grebe Rhonda²^ORCID,Hose Stacey¹,Weiss Joseph¹,Luo Tianqi²,Mishra Subrata²,Riazuddin S. Amer²,Ghosh Arkasubhra³,Handa James T.²,Lutty Gerard A.²,Zigler J. Samuel²,Sinha Debasish¹²

Affiliation:

1. Glia Research Laboratory, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

2. The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, India

Funder

Knights Templar Eye Foundation

National Eye Institute

Jennifer Salvitti Davis Chair in Ophthalmology, UPitt

Research to Prevent Blindness

University of Pittsburgh

Publisher

Informa UK Limited